Friday, 20 November 2026European Markets

HOFSETH BIOCARE Stock Over 22% Up In The Last 10 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of HOFSETH BIOCARE (Oslo Børs Benchmark Index_GI: HBC.OL) rose by a staggering 22.4% in 10 sessions from kr2.5 to kr3.06 at 13:38 EST on Thursday, following the last session's upward trend. Oslo Børs Benchmark Index_GI is jumping 0.54% to kr1,249.22, after two consecutive sessions in a row of gains.

HOFSETH BIOCARE's last close was kr2.88, 46.86% below its 52-week high of kr5.42.

About HOFSETH BIOCARE

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for supporting healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome (IBS) and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo, an hair, skin, and nails health treatment and antioxidant; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

Earnings Per Share

As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.31.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -94.78%.

Volume

Today's last reported volume for HOFSETH BIOCARE is 184259 which is 31.16% below its average volume of 127327.

Moving Average

HOFSETH BIOCARE's value is higher than its 50-day moving average of kr2.89 and below its 200-day moving average of kr3.27.

More news about HOFSETH BIOCARE (HBC.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 2 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›